European Companies Search Engine

8 EU fundings (€256,320): Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases … BdlYear 2019 EU Research and Innovation programme "Horizon"

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: UCB Biopharma B.V., Anderlecht, Belgium.

Creative Commons License The visualizations for "8 EU fundings (€256,320): Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.